Pradžia › Pučio takų vėžys
Pučio takų vėžys klinikiniai tyrimai JAV ieško dalyvių
40 tyrimai dėl Pučio takų vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX18 tyrimai
- Los Angeles, CA11 tyrimai
- Boston, MA11 tyrimai
- New York City, NY10 tyrimai
- Nashville, TN9 tyrimai
- San Antonio, TX8 tyrimai
- Baltimore, MD8 tyrimai
- Washington, DC7 tyrimai
- Arlington, VA7 tyrimai
- Pittsburgh, PA7 tyrimai
- Baldwin Park, CA6 tyrimai
- Cleveland, OH6 tyrimai
- Dallas, TX6 tyrimai
- Columbus, OH6 tyrimai
- Madison, WI6 tyrimai
- Philadelphia, PA6 tyrimai
- Detroit, MI5 tyrimai
- Louisville, KY5 tyrimai
- Tampa, FL5 tyrimai
- Miami, FL5 tyrimai
- Orange, CA4 tyrimai
- Seattle, WA4 tyrimai
- Aurora, CO4 tyrimai
- Queens, NY4 tyrimai
- Orlando, FL4 tyrimai
- Buffalo, NY3 tyrimai
- Edison, NJ3 tyrimai
- Santa Monica, CA3 tyrimai
- Salt Lake City, UT3 tyrimai
- St. Louis, MO3 tyrimai
- San Diego, CA3 tyrimai
- Grand Rapids, MI3 tyrimai
- Chicago, IL3 tyrimai
- Tucson, AZ3 tyrimai
- Providence, RI3 tyrimai
- Denver, CO3 tyrimai
- Portland, OR3 tyrimai
- Birmingham, AL3 tyrimai
Pagal valstiją
- Alabama3 tyrimai
- Arizona4 tyrimai
- Džordžija4 tyrimai
- Florida14 tyrimai
- Ilinoisas5 tyrimai
- Kalifornija20 tyrimai
- Kentukis6 tyrimai
- Koloradas7 tyrimai
- Kolumbijos apskritis4 tyrimai
- Konektikutas3 tyrimai
- Masčusetsas11 tyrimai
- Merilendas11 tyrimai
- Minesota5 tyrimai
- Misūris4 tyrimai
- Mičiganas9 tyrimai
- New Jersey5 tyrimai
- New York15 tyrimai
- Ohio10 tyrimai
- Oregon3 tyrimai
- Pennsylvania10 tyrimai
- Rhode Island3 tyrimai
- Tennessee10 tyrimai
- Texas23 tyrimai
- Utah4 tyrimai
- Virginia9 tyrimai
- Washington5 tyrimai
- Wisconsin6 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 2 iki 100 · Visoms lytims · Atnaujinta 2026-10-02 · NCT01950572A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06219941A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07265674Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT05482893A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06428409Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-23 · NCT05489211Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Renkami dalyviai2 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07146646Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT06282575SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT07812805Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06293898CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06548412AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07038343Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-24 · NCT06084481Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05517811A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT06774963Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-19 · NCT06467357A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT05592626A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT06330064D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT06622057A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT07458347Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.